Waltz Health

Pharmaceutical marketplace for prescription savings

Chicago, Illinois, United States

About Waltz Health

Waltz Health operates a marketplace designed to simplify the process of obtaining prescription medications. It addresses the challenges of high costs and lack of transparency in the pharmaceutical industry by allowing consumers to search for and compare prices across various pharmacy cards. This service, known as the "Complete Cash Card Solution with Marketplace Search," helps users find the best prices for their prescriptions, ultimately saving them money and enabling informed healthcare decisions. Unlike many competitors, Waltz Health focuses on creating partnerships with pharmacies to enhance pricing competitiveness and drive consumer traffic, benefiting both consumers and pharmacies. The company's goal is to create a more transparent and efficient pharmaceutical marketplace that empowers consumers and reduces the complexities associated with obtaining medications.

Chicago, IllinoisHeadquarters
2021Year Founded
$34.4MTotal Funding
SERIES_ACompany Stage
Fintech, HealthcareIndustries
11-50Employees

Benefits

Competitive compensation
Stock options
Flexible vacation
Medical, dental, vision
401k
Commuter benefits

Risks

Increased competition from established pharmaceutical tech players may challenge market position.
Potential regulatory changes could impose additional compliance costs on digital health platforms.
Entry into the Medicare market introduces complexities in federal regulations and reimbursement models.

Differentiation

Waltz Health leverages AI to offer personalized medication recommendations, enhancing consumer experience.
The company integrates blockchain for transparency in the pharmaceutical supply chain.
Waltz Health's Marketplace Search technology provides a unique, cost-saving tool for Medicare beneficiaries.

Upsides

AI-driven medication recommendations align with the trend of personalized healthcare solutions.
Partnerships with CerpassRx and Noom expand Waltz Health's reach in specialty drug management.
Recent $35.4M funding round supports growth and technological advancements.

Funding

Total raised$34.43 M
Latest valuation$177.00 M
StageSERIES_A